UnitedHealth Group Incorporated $UNH Shares Sold by State of Alaska Department of Revenue

Key Points

• State of Alaska Department of Revenue reduced its stake in UnitedHealth Group (UNH) by 8.0% in Q4, selling 9,928 shares and retaining 114,687 shares valued at about $37.86 million.
• CMS finalized a ~2.48% increase to 2027 Medicare Advantage reimbursements, triggering analyst price‑target raises, upgrades and reported high‑profile buying (including Warren Buffett), though some analysts caution the rally may be short‑lived given utilization and cost pressures.
• UNH beat quarterly EPS ($2.11 vs. $2.09), pays a quarterly dividend of $2.21 (annualized $8.84, ~2.9% yield), and trades with a market cap around $276.5 billion amid mixed analyst ratings and a consensus target near $363.42.

State of Alaska Department of Revenue decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 114,687 shares of the healthcare conglomerate's stock after selling 9,928 shares during the quarter. State of Alaska Department of Revenue's holdings in UnitedHealth Group were worth $37,858,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Beacon Financial Strategies CORP acquired a new stake in UnitedHealth Group during the 4th quarter worth about $26,000. Foster Dykema Cabot & Partners LLC lifted its position in UnitedHealth Group by 69.4% during the 3rd quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate's stock worth $29,000 after acquiring an additional 34 shares during the period. 1248 Management LLC purchased a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $29,000. Holos Integrated Wealth LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at about $29,000. Finally, Hurley Capital LLC raised its stake in shares of UnitedHealth Group by 81.6% during the 3rd quarter. Hurley Capital LLC now owns 89 shares of the healthcare conglomerate's stock valued at $31,000 after buying an additional 40 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: CMS finalized a ~2.48% increase to 2027 Medicare Advantage reimbursements, which analysts say adds meaningful revenue/earnings upside for large MA players like UNH and drove an immediate sentiment lift. UnitedHealth Stock Edges Higher After Medicare Advantage Payment Update
• Positive Sentiment: Street reaction includes price‑target raises and upgrades (e.g., Bernstein boosted its UNH target to $411 and HSBC upgraded to Hold), signaling increased analyst conviction that the CMS action improves the outlook. Sanford C. Bernstein Boosts UnitedHealth Group NYSE: UNH Price Target to $411.00
• Positive Sentiment: High-profile buying (reporting that Warren Buffett added ~5M UNH shares during the pullback) has been cited as a confidence signal that helped support the post‑CMS bounce. Warren Buffett bought 5M UnitedHealth shares as it tanked. A $13B Medicare boosted it. Was he right?
• Neutral Sentiment: Analyst commentary and valuation notes are being updated to reflect the CMS increase; many firms still point to long‑term growth from Optum and diversification even as near‑term math changes. Market attention and re‑ratings are ongoing. A Look At UnitedHealth Group (UNH) Valuation After The Medicare Advantage Payment Increase
• Neutral Sentiment: Coverage pieces note that CMS relief helps margins but rising utilization and medical cost inflation remain a drag; the net impact depends on how much cost trends moderate versus reimbursement gains. Can UnitedHealth Ease Margin Pressure on CMS Tailwinds?
• Negative Sentiment: Some analysts and commentators warn the CMS-driven rally may be short‑lived — cautioning that one policy bump doesn't solve utilization and cost issues, and that upcoming earnings could re‑test the move. UnitedHealth Stock Jumps on Better-Than-Expected Medicare Advantage Rates. Here's Why the Rally Might Be Short-Lived
• Negative Sentiment: Critical takes argue investors should be cautious about extrapolating CMS relief into sustained outperformance — skepticism around durability of margin improvement and idiosyncratic risks remain. UnitedHealth Group: Don't Drink The CMS Kool-Aid

UnitedHealth Group Trading Up 0.1%

Shares of UnitedHealth Group stock opened at $304.63 on Monday. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $606.36. The stock has a market cap of $276.50 billion, a P/E ratio of 23.10, a P/E/G ratio of 1.40 and a beta of 0.40. The stock's 50 day simple moving average is $283.01 and its 200-day simple moving average is $318.17. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, beating analysts' consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The firm had revenue of $113.73 billion for the quarter, compared to analysts' expectations of $113.38 billion. During the same period in the prior year, the firm posted $6.81 earnings per share. The firm's quarterly revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Investors of record on Monday, March 9th were issued a $2.21 dividend. The ex-dividend date was Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. UnitedHealth Group's dividend payout ratio is currently 67.02%.

Analyst Ratings Changes

Several equities analysts recently weighed in on UNH shares. Oppenheimer cut their price target on UnitedHealth Group from $415.00 to $385.00 and set an "outperform" rating for the company in a research note on Wednesday, January 28th. Mizuho cut their price target on UnitedHealth Group from $430.00 to $350.00 and set an "outperform" rating for the company in a research note on Thursday, February 5th. HSBC upgraded UnitedHealth Group from a "reduce" rating to a "hold" rating and set a $300.00 price objective for the company in a research note on Tuesday, April 7th. Truist Financial cut their price objective on UnitedHealth Group from $410.00 to $370.00 and set a "buy" rating for the company in a research note on Monday, February 2nd. Finally, JPMorgan Chase & Co. cut their price objective on UnitedHealth Group from $425.00 to $389.00 and set an "overweight" rating for the company in a research note on Monday, February 2nd. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $363.42.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.